• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
KRYS

KRYS

Krystal Biotech, Inc.

NASDAQHealthcareBiotechnologyUS

USD301.82

+8.61 (+2.94%)

Rating:A-

Company Profile

CEO

Krish S. Krishnan

IPO Date

2017-09-20

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$292.22

Prev. Close

$293.21

Day Low

$290.04

Day High

$304.90

52W Low

$127.99

52W High

$319.48

Market Cap

$8.90B

Volume

0.22M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.8%

Avg Negative

1.3%

Avg Neutral

68.9%

News Feed

Krystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the Treatment of TGM-1 Associated Ichthyosis

GlobeNewsWire·7/1/2021·↑ positive

New Strong Sell Stocks for May 21st

Zacks Investment Research·5/21/2021·↑ positive

Krystal Biotech Reports First Quarter 2021 Financial Results and Provides Update on Operational Progress

GlobeNewsWire
·5/10/2021
·↑ positive

Krystal Biotech Announces Virtual Presentation of Data from its Vector-Encoded-Antibody Platform at ASGCT

GlobeNewsWire·4/27/2021·↑ positive

Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB

GlobeNewsWire·4/26/2021·↑ positive

Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial of B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa

GlobeNewsWire·3/30/2021·↑ positive

Krystal Biotech to Participate in Upcoming Investor Conferences

GlobeNewsWire·3/29/2021·↑ positive

Krystal Biotech Provides Update on Operational Progress and Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewsWire·3/1/2021·↑ positive

Krystal Biotech to Present at the Cowen 41st Annual Health Care Conference

GlobeNewsWire·2/23/2021·↑ positive

Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock

GlobeNewsWire·2/2/2021·↑ positive